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Available online 6 May 2019AbstractPurpose: To review the clinical features, diagnosis, treatment modalities, and prognosis of Bartonella-associated neuroretinitis.
Methods: This is a narrative review on Bartonella-associated neuroretinitis including general and ophthalmological aspects of the disease. A
comprehensive literature review between January 1950 and September 2018 was conducted in PubMed database. Epidemiology, clinical fea-
tures, diagnosis, treatment, and prognosis of Bartonella neuroretinitis were reviewed.
Results: Cat scratch disease (CSD) is a worldwide distributed systemic infectious disease caused by a bacterium, Bartonella henselae (B.
henselae) which is usually transmitted to humans through contact with infected cats. Ocular manifestations of CSD are diverse, with neuro-
retinitis and superficial retinal infiltrates being the most common and typical manifestations. Neuroretinitis typically presents as optic disc edema
with a partial or complete macular star in association with mild vitritis. Macular star may be absent at the initial presentation, becoming evident
1e2 weeks after the onset of optic disc edema. Diagnosis of CSD is confirmed by reliable laboratory tests. Neuroretinitis usually has a self-
limited course. Antibiotic therapy is required for severe systemic disease and vision-threatening ocular involvement. The adjunctive use of
oral corticosteroids may further improve the visual outcome.
Conclusions: The diagnosis of Bartonella-associated neuroretinitis is based on typical clinical findings and positive serology. The prognosis is
usually favorable in immunocompetent individuals.
Copyright © 2019, Iranian Society of Ophthalmology. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Cat scratch disease (CSD), also known as cat scratch fever,
is a self-limited, systemic infectious disease caused by a small,
fastidious, gram-negative intracellular bacillus Bartonella
henselae (B. henselae).1,2
CSD was first described in 1950 by Debre et al.3 However,
the causative agent was first identified in 1983 by Wear and
associates.4 Humans may catch the infection throughCompeting interests: The authors declare no financial interest.
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).scratches, licks, and bites of cats or kittens.1 Humans trans-
mission can also occur secondary to tick bites.1 The most
common systemic manifestation consists of lymphadenitis
involving the lymph nodes draining sites of inoculation.1
Many ocular manifestations may be related to CSD, with
neuroretinitis and focal retinochoroiditis/retinal infiltrates
being the most common clinical forms of ocular CSD.1,5e7
Conversely, B. henselae is among the most common causes
of neuroretinitis.8,9
The primary aim of this article was to review the clinical
features, diagnosis, treatment modalities, and prognosis of
Bartonella-associated neuroretinitis.osting by Elsevier B.V. This is an open access article under the CC BY-NC-ND
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The literature review for this study was based on a search in
PubMed/Medline and Scopus databases to identify original
articles, reviews, and case reports between January 1950 and
September 2018 in English language regarding Bartonella
neuroretinitis. The following keywords were used: (“Barto-
nella” OR “Bartonella henselae” OR “Bartonella Infection”
OR “Cat-Scratch Disease”) AND (“Neuroretinitis” OR “Eye”
OR “Uveitis” OR “Optic Neuropathy”). All selected articles
were reviewed thoroughly by the authors to review epidemi-
ology, pathogenesis, clinical features, diagnosis, treatment,
and prognosis of Bartonella neuroretinitis.
ResultsTable 1
Ophthalmic manifestations of Bartonella infection.
Eye compartment Clinical findings
Adnexal manifestations Parinaud oculoglandular syndrome
Vitreous changes Intermediate uveitis
Vitreous hemorrhage
Retinal/choroidal manifestations Inner retinitis
Chorioretinitis
Retinal vascular manifestations Retinal vasculitis
Angiomatous-like proliferation
Branch retinal arteriolar occlusion
Branch retinal vein occlusion




Optic nerve manifestations Neuroretinitis
Optic disc edema
Optic nerve head massGeneral aspects of cat scratch disease
Epidemiology
CSD is a worldwide distributed zoonosis.10 Cats are the
primary reservoir for B. henselae, with the cat flea (Ctenoce-
phalides felis) being the main transmission vector among
cats11,12 and occasionally to humans. The incidence of CSD in
the United States is roughly 22,000 cases per year.13 The
seroprevalence ranges from 2.0 to 32.38% in Eastern China14
and from 12.8 to 13.7% in Brazil.15 Recent data show that the
incidence of CSD is 4.7 per 100.000 persons less than 65 years
of age.16 B. henselae is usually transmitted from cats to
humans through scratches or by the contamination of super-
ficial injuries.17,18 The infection is not known to be transmitted
from human to human. CSD cases have been reported at all
times of the year but may increase during fall and winter.19 B.
henselae infection is more common in children and young
adults.20 The veterinary profession is also a risk factor for
CSD infection.1,21
Pathogenesis
Humans infection occurs secondary to scratches, licks,
bites of cats or kittens, and rarely tick bites.1 The infectious
agent causes in the inoculation site a focal granuloma with
necrosis at the center and surrounding histiocytes, lympho-
cytes, and giant cells. Systemic manifestations of CSD are
influenced by pathogen-related factors and the host's im-
mune status.1 The exact pathogenesis of CSD-associated
neuroretinitis remains to be elucidated. The optic nerve
involvement might be caused by optic nerve or intraocular
infection by Bartonella, an immune response to bacterial
infection, or a combination of infectious and parainfectious
mechanisms.9 The inflammation of the optic disc causes
exudation of fluid into the peripapillary retinal leading to
serous retinal detachment and the subsequent appearance of
macular exudates with a partial or complete star pattern
around the fovea.
Systemic disease
Primary inoculation through a cat scratch or bite often re-
sults in a local infection. An erythematous papule, vesicle, ormacule often develops at the site of inoculation. A few weeks
later, systemic reaction including regional lymphadenitis, low-
grade fever, malaise, chills, excessive sweating during sleep,
fatigue, and headache occurs.22,23 Most patients experience
self-limited disease in the inoculation site with mild systemic
symptoms that resolve within several months.24 However, a
small subset of individuals, particularly immunocompromised
patients, may develop extra nodal dissemination with life-
threatening complications, such as endocarditis,1 meningi-
tis,25 encephalitis,25 arthritis,26 osteomyelitis,26 pneumonia,1
and hepatosplenic involvement.26
Ocular disease
Ocular involvement occurs in 5e10% of individuals with
CSD.27 The eye may be the primary site of inoculation leading
to Parinaud oculoglandular syndrome, characterized by infec-
tion of the conjunctiva and eyelids, associated with regional
lymphadenopathy. Different ocular manifestations may occur
following the systemic disease by 2e3 weeks. These manifes-
tations include neuroretinitis, optic neuropathy, and an array of
other forms of intraocular inflammation (Table 1).1,20,28,29Clinical features of neuroretinitisNeuroretinitis is defined as inflammation of the optic nerve
and peripapillary retina and is characterized by optic disc
edema and subsequent formation of a macular star. Neuro-
retinitis is usually unilateral but may be bilateral in both
immunocompetent and immunocompromised patients.19
Ocular complaints usually begin 2e3 weeks after the onset
of systemic symptoms. The decrease in vision is the most
common ocular symptom.6 Visual acuity at presentation varies
from light perception to 20/20. There are usually a relative
afferent pupillary defect, a visual field defect, and dyschro-
matopsia.30 Cells and flare in the anterior chamber are seen at
times, and a mild vitritis is common. Fundoscopic findings
typically include optic disc edema and lipid exudation in the
macula arranged in a complete or incomplete star
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is usually present in the nasal macula. The optic disc is the
primary target of inflammation in neuroretinitis.32 The mac-
ular star may be absent at initial presentation. It usually de-
velops roughly 1e2 weeks after the onset of optic disc edema.
The disc edema begins to decrease in 2 weeks and usually
shows complete resolution in 8e12 weeks. The macular star
decreases in 4 weeks but may be present for up to 1 year.33
The optic disc edema is usually accompanied by papillary
and peripapillary telangiectatic vessels (Fig. 2). Besides, it is
commonly associated with peripapillary retinal thickening and
exudative retinal detachment (Fig. 3).34 Intraretinal hemor-
rhages may be seen.35 Patients may present with a prominent
peripapillary angiomatous lesion or optic disc, which may
mimic other conditions such as toxocariasis or tumors.36Fig. 2. Fundus photograph of the left eye of a patient with cat scratch diseaseOther posterior segment changes(CSD) shows a prominent vascularized optic nerve head mass associated with
peripapillary exudative retinal detachment (Courtesy, Andre Curi).Small or large white retinal lesions consistent with inner
retinitis or retinochoroiditis represent another common ocular
manifestation of CSD. Retinal infiltrates and retinochoroiditis
were reported as the most common findings in some
studies.5e7
These lesions have typically a juxtavascular location and
may be associated or not with neuroretinitis (Fig. 3).6,19,24,37
The lesions fade slowly, imparting atrophic chorioretinalFig. 1. (A) Fundus photograph of the right eye of a 44-year-old patient with a serolo
associated with a complete macular star and exudative retinal detachment. Early-p
and staining of the optic disc (D) Fundus photograph taken 4 weeks later shows a
exudates around the optic disc.scarring onto the damaged retina. Telangectasia or an
angiomatous-like proliferation of retinal capillaries may be
associated and are better shown by fluorescein angiography.38,39
Retinal vascular occlusions, predominantly arteriolar occlu-
sions, may develop in ocular bartonellosis.40 Branch retinal
artery occlusion6,41 or less often branch retinal veingically confirmed cat scratch disease (CSD) shows a marked optic disc edema
hase (B) and late-phase (C) Fluorescein angiograms show progressive leakage
partial resolution of the macular hard exudates, with the appearance of new
Fig. 3. Cat scratch disease (CSD) neuroretinitis in the right eye of a 19-year-old woman. (A) Fundus photograph shows optic disc edema with a partial macular star
associated with a white retinal lesion (arrow) (B) Early-phase fluorescein angiogram shows hypofluorescence of the retinal lesion (arrow) (C) Late-phase fluo-
rescein angiogram shows optic disc leakage and staining of the retinal lesion (arrow) (D) Swept-source OCT shows a marked retinal thickening nasally (white
asterisk) associated with a macular serous retinal detachment (Courtesy, Walid Zbiba).
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A case of the central retinal artery and central vein occlusion
has also been described.7
Other rare ocular findings associated with CSD may include
inflammatory retinal mass,42 subretinal mass associated with an
abnormal vascular network among patients with human im-
munodeficiency virus infection,7 intermediate uveitis and
retinal vasculitis,43 panuveitis with manifestations mimicking
Vogt-Koyanagi-Harada disease,44 exudative macular detach-
ment without associated retinitis or neuroretinitis,45,46 macular
hole,47 vitreous hemorrhage,48 and endophthalmitis.49Imaging and ancillary testingFluorescein angiography demonstrates early papillary and
peripapillary telangiectasia with late marked fluorescein
leakage from the optic disc and vessels (Figs. 1 and 3).50 There
is no associated perifoveal capillary leakage (Figs. 1 and 3).51
Indocyanine green angiography may also show optic disc
hyperfluorescence without associated choroidal involvement.52
Fundus autofluorescence may be helpful for demonstrating
hyperautofluorescent lesions corresponding to macular
exudates.53
Optical coherence tomography (OCT) typically shows the
thickening of the neurosensory retina in the peripapillary area
and subretinal fluid accumulation.50,54
Retinal exudates appear as hyperreflective lesions in the
outer plexiform layer. OCT can assist the clinicians to detect
retinal findings that are not visible on clinical exam particu-
larly in the early stages of Bartonella neuroretinitis (Fig. 3).Subclinical evidence of subretinal fluid accumulation and
thickening of the neurosensory retina can be identified earlier
on OCT compared with biomicroscopy.54
OCT angiography, a new non-invasive imaging modality,
may be useful in detecting optic disc telangiectatic vessels
(Fig. 4).
Visual field testing often demonstrates a cecocentral, cen-
tral, or paracentral scotoma, or an enlarged blind spot.29
Other functional alterations include color vision abnor-
malities and reduction in average visually evoked potential
(VEP) with normal electroretinogram.19DiagnosisThe diagnosis of CSD-associated neuroretinitis is based on
clinical findings including young age, history of contact with a
cat, typical neuroretinitis, systemic symptoms, and positive
serology.
The culture of B. henselae from blood patient is difficult
and rarely successful.
Serological tests are more reliable based on immunoglob-
ulin G (IgG) and immunoglobulin M (IgM) detection.
The indirect fluorescent antibody (IFA) test is the most
reliable method with high specificity of 95%. However, cross
reactivities have been reported in patients with Coxiella bur-
netii infection, Chlamydophila infection, Brucella sp and non-
henselae Bartonella infections,55 making the sensitivity less
strong and variable in reports especially for IgM detection.
IgM detecting by enzyme-linked immunoassays (EIA) was
found to have variable sensitivity in different reports, making
Fig. 4. Swept-Source OCT angiography showing peripapillary telangiectatic
vessels in a patient with cat scratch disease (CSD)-associated neuroretinitis.
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blot analysis for the diagnosis of CSD is not yet proven.
IgM positivity indicates acute disease. IgG titers exceeding
1:256 confirm CSD. Titers between 1:64 and 1:256 suggest
possible CSD, and the serology should be performed again
10e14 days later.Table 2
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Branch retinal vein occlusion
Anterior ischemic optic neuropathyPolymerase chain reaction (PCR) for the detection of B.
henselae 16S ribosomal RNA gene in patients’ tissues such
as lymph nodes is a more advanced technique that has been
recently used for CSD diagnosis.57 There are few reports
about PCR in aqueous humor.58 Histological examination of
iris specimen was reported in a child with iris nodule
and showed granulomatous inflammation with a central
necrosis.59Differential diagnosisEtiologies of neuroretinitis can be divided into infectious
and noninfectious diseases. Although CSD was found to be
the leading cause of neuroretinitis, other infectious or in-
flammatory diseases should be considered in the differential
diagnosis including toxoplasmosis, toxocariasis, tubercu-
losis, syphilis, Lyme disease, rickettsiosis, dengue fever,
chikungunya, sarcoidosis, Behçet disease, and other condi-
tions31,32 (Table 2). The differential diagnosis is based on
history, epidemiological data, systemic manifestations, and
the pattern of ocular involvement. Other possible causes of
optic disc swelling associated with macular star should be
excluded including severe high blood pressure, diabetes
mellitus, intracranial hypertension, branch retinal vein oc-
clusion, and nonarteritic or arteritic anterior ischemic optic
neuropathy (Table 2).7,30,60e62 Small inner retinal infiltrates
in the posterior pole may mimic cotton-wool spots. However,
unlike these ischemic lesions, retinal infiltrates do not
necessarily follow first-order arterioles and do notg features
roiditis, retino-choroidal scar, moderate to severe vitritis,
erior uveitis
ong children, unifocal vitreo-retinal granuloma,
vitritis
erior uveitis, occlusive periphlebitis, choroidal involvement
logical testing mandatory to exclude this condition
rea, erythema migrans, chronic arthritis, neurological involvement,
c ocular manifestations
rea, high fever with skin rash, small and large retinal infiltrates, mild vitritis
rea, systemic symptoms ranging from flu-like illness to hemorrhagic
is, diffuse retinal vasculitis
rea, flu like illness, polyarthralgia, non-granulomatous anterior uveitis,
tes
atous anterior uveitis, segmental periphlebitis, multifocal choroiditis,
s
ent, acute non-granulomatous anterior uveitis, hypopyon, periphlebitis
plications, transient retinal infiltrates, severe diffuse vitritis
ack of inflammatory reaction, associated features suggestive of specific entity
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fluorescein angiography.TreatmentThere is no consensus on the management modalities of
CSD or its ocular manifestations. CSD is usually characterized
by a self-limited course in immunocompetent patients. There
is no recommendation to treat mild to moderate systemic CSD.
However, severe ocular or systemic complications of CSD and
immunocompromised patients should be treated. Antibiotic
options may include doxycycline, azithromycin, erythro-
mycin, ciprofloxacin, trimethoprim-sulfamethoxazole, genta-
micin, or rifampin.23,63
Immunocompetent individuals aged more than 8 years are
typically prescribed doxycycline, 100 mg per os twice a day
for 2e4 weeks. This antibiotic may be given intravenously or
used in association with rifampin (300 mg per os twice a day)
in severe cases. A prolonged therapeutic regimen (4 months) is
required in immunocompromised patients.20 Children may be
prescribed azithromycin. Paradoxical response to antibiotics is
possible in CSD-associated ocular involvement.64 Prescription
of oral corticosteroids may be considered, in association with
antibiotic therapy, in ocular CSD with severe inflammatory
reaction. Recent data shows that patients treated with antibi-
otics and oral corticosteroids have better final visual acuity
than patients treated by antibiotics alone.65
Preventive measures of CSD include washing hands after
contact with cats, disinfection of injuries following a cat
scratch or bite,16 and limiting of the number of stray cats at
greater risk for B. henselae bacteremia.66
Prolonged use of doxycycline or alternatively a macrolide
may be helpful for prevention of CSD recurrences in HIV-
positive patients.20PrognosisCSD-associated neuroretinitis is usually characterized by a
self-limited course in immunocompetent patients, with gradual
resolution of optic disc edema and hard exudates (Fig. 1).
Most patients will recover a normal visual acuity within a few
weeks to months.19 Macular exudates usually disappear within
approximately 8e12 weeks, but they may persist for up to one
year. A mild or moderate optic disc pallor may rarely persist.30
Retinal atrophy or residual retinal pigment epithelium changes
may also occur as sequelae of severe exudative maculopathy,
dense retinal infiltrates, or occlusive vasculitis.
Discussion
In the present article, we reviewed the most recent
available data in the literature regarding Bartonella neuro-
retinitis that are relevant to ophthalmologist in every day
clinical practice. CSD is a worldwide distributed systemic
infectious disease caused by a bacterium, B. henselae, and
transmitted to humans through contact with infected cats.
Systemic manifestations are usually mild and self-limited inimmunocompetent patients, while immunocompromised in-
dividuals are at risk of developing severe, life-threatening
complications.1,25,26
CSD is the first condition to be considered in the differ-
ential diagnosis of neuroretinitis.1,5e7 Typical fundoscopic
findings include unilateral optic disc edema and lipid
exudation in the macula arranged in a complete or incom-
plete star configuration associated with mild vitritis. It is
important not to miss a diagnosis of early acute neuroretinitis
in the absence of evident macular star that usually develops
roughly 1e2 weeks after the onset of optic disc edema. Other
clues to the diagnosis of CSD include optic disc telangiec-
tasia, peripapillary exudative retinal detachment, superficial
retinal infiltrates, and occlusion of small branch retinal
arterioles.38e41
Fluorescein angiography confirms that the primary site of
inflammation is the optic nerve head, showing progressive
optic disc leakage with no evidence of capillary abnormalities
in the macular area.51 Spectral domain optical coherence to-
mography (SD-OCT) is an essential imaging modality for the
detection, evaluation, and monitoring of exudative retinal
detachment and retinal thickening associated with optic disc
edema.54 Optical coherence tomography angiography (OCTA)
may be a useful tool for non-invasive evaluation of optic disc
and retinal vascular changes occurring in patients with CSD
neuroretinitis.
The diagnosis of CSD-associated neuroretinitis primarily
relies on clinical findings including young age, history of
contact with cat, systemic symptoms, and typical ocular
involvement.1 Besides CSD, an array of other infectious and
inflammatory conditions may present with neuroretinitis
including toxoplasmosis, rickettsiosis, tuberculosis, syphilis,
and sarcoidosis.31,32 Clinicians should also be aware that optic
disc edema with macular star associated with unknown ma-
lignant hypertension or other non-inflammatory conditions
may masquerade as neuroretinitis.62
The IFA test is the most used method to detect IgM.
However, cross reactivities are possible with other in-
fections.55 IgM-enzyme-linked immunoassays, IgM-Western
blot analysis, and PCR are less commonly used.
In daily practice, a diagnosis of typical Bartonella-
associated neuroretinitis is primarily based on clinical find-
ings. Multimodal imaging is useful in characterizing and
analyzing optic disc involvement and associated chorioretinal
changes in both typical and atypical clinical presentations.
Positive serology for B. henselae is, however, mandatory to
establish the definitive diagnosis. Nevertheless, an empiric
antibiotherapy could be started before serological results
become available. Alternative diagnoses to Bartonella neuro-
retinitis should be excluded, especially in atypical clinical
presentations. They include other infectious and inflammatory
etiologies of neuroretinitis and other causes of optic disc
swelling with macular star.
Treatment guidelines for systemic and ocular CSD remain
poorly defined, as most patients have a self-limited course,
with no randomized controlled trials performed. However,
antibiotic treatment is often considered in severe systemic
260 I. Ksiaa et al. / Journal of Current Ophthalmology 31 (2019) 254e261disease, immunocompromised patients, or sight-threatening
ocular involvement, including neuroretinitis.20 Recent data
show that use of oral corticosteroids in combination with an-
tibiotics may further improve the visual outcome in patients
with CSD neuroretinitis.65
Preventive measures for CSD would require avoidance of
close contacts with cats and cat fleas, with increased aware-
ness of the risk of cat scratches.References
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